• Study on the Safety and Immune Response of RSVPreF3 Vaccine for Respiratory Syncytial Virus in Adults Aged 60 and Above

    Not recruiting

    3 1 1 1
    Finland Germany
  • Study of Durvalumab with Gemcitabine and Cisplatin for Patients with Advanced Biliary Tract Cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Bulgaria France Italy Poland
  • Study on Guselkumab for Patients with Moderate-to-Severe Plaque Psoriasis

    Not recruiting

    3 1
    Investigated diseases:
    Germany
  • Study on Tiotropium for Preventing Severe Asthma Attacks in Preschool Children with Uncontrolled Asthma

    Not recruiting

    3 1
    Investigated diseases:
    Germany
  • Study on Long-Term Safety and Tolerability of Iptacopan for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

    Not recruiting

    3 1 1
    Investigated diseases:
    Czechia France Germany Italy Lithuania The Netherlands +1
  • Study Comparing Chemotherapy Alone to Chemotherapy with Nivolumab or Nivolumab and BMS-986205 for Patients with Muscle-Invasive Bladder Cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium Finland France Germany Greece +5
  • Study of BMS-986012, carboplatin, etoposide and nivolumab combination as first treatment for patients with extensive-stage small cell lung cancer

    Not recruiting

    2 1 1 1
    Belgium Greece Italy The Netherlands Poland Romania +1
  • Study on the Safety and Effects of Volrustomig and Axitinib for Patients with Advanced Kidney Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    France Spain
  • Study on Reducing Hormone Therapy Duration with Exemestane, Letrozole, and Anastrozole in Post-Menopausal Women with Low-Risk Hormone-Sensitive Breast Cancer

    Not recruiting

    2 1 1 1
    France
  • Study on Giredestrant and Everolimus for Patients with Estrogen Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer

    Not recruiting

    3 1 1 1
    Germany Greece Italy Spain

powered by